Clinical trial
Lofexidine for Inpatient Opiate Detox
NCT00235729 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00235729 |
|---|---|
| Title | Lofexidine for Inpatient Opiate Detox |
| Official title | CSP #1024 - A Phase III, Randomized, Multi-Center, Double Blind, Placebo-Controlled Study of Safety and Efficacy of Lofexidine for Relief of Symptoms in Subjects Undergoing Inpatient Opiate Detoxification. |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH USWM, LLC (dba US WorldMeds) Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Opiate Addiction |
| Intervention type | Drug |
| Interventions | Lofexidine, Placebo |
| Enrollment | 264 |
| Start date | Jun 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Oct 10, 2005 |
| Last update posted | Mar 20, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: